Reasonable layout, adjust and optimize the economic structure and industrial product structure, in order to solve the environmental impact of the "structural" pollution and waste of resources and energy.
Wanli Pharmaceutical Valley, Yichun Yuanzhou Pharmaceutical Industrial Park, Zhangshu Fucheng Pharmaceutical Park, Ji'an High-tech Development Zone, Pingxiang Xuanfeng Bio-industrial Park, Jinxian Medical Devices Industrial Park, and other major core parks in the development.
"Twelfth Five-Year Plan" and to 2020, the biological and new pharmaceutical market growth rate will be significantly higher than the average growth rate of other industrial markets, as one of the emerging industries in Jiangxi biological and new pharmaceutical industry will usher in a good opportunity for development.
2013 China (Nanchang) International Pharmaceutical Industry and Technology Exhibition:
Jiangxi Province, biological and new pharmaceutical industry "Twelfth Five-Year Plan" development plan pointed out that the biological and new pharmaceutical industry is one of the strategic emerging industries in the province to achieve "scientific development, catching up and rising green "
In 2010, the province's pharmaceutical industry completed a cumulative total industrial output value of 49.625 billion yuan, an increase of 4.27 times over 2005; the completion of the main business income of 49.353 billion yuan.
Increase of 2.92 compared with 2005, an increase of 4.8 percentage points higher than the national average level of the same industry; industrial scale has expanded significantly. It is expected that by 2015, the province's bio-industry sales revenue will exceed 180 billion yuan.